{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 470617884
| IUPAC_name = ''N''-(1-adamantyl)-2-[2-(dimethylamino)ethoxy]acetamide
| image = Tromantadine.svg
| alt = Skeletal formula
<!--Clinical data-->
| tradename = Viru-Merz
| Drugs.com = {{drugs.com|international|tromantadine}}
| pregnancy_category =
| legal_US = Not FDA-approved
| legal_status = [[Over-the-counter drug|OTC]] <small>([[Russia|RU]])</small>
| routes_of_administration = [[Topical]] ([[gel]])
<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| excretion =  
<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 53783-83-8
| ATC_prefix = D06
| ATC_suffix = BB02
| ATC_supplemental = {{ATC|J05|AC03}}
| PubChem = 64377
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 57947
| NIAID_ChemDB = 007760
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = H191JFG8WA
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07199
<!--Chemical data-->
| C=16 | H=28 | N=2 | O=2
| molecular_weight = 280.406 g/mol
| SMILES = O=C(NC13CC2CC(CC(C1)C2)C3)COCCN(C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C16H28N2O2/c1-18(2)3-4-20-11-15(19)17-16-8-12-5-13(9-16)7-14(6-12)10-16/h12-14H,3-11H2,1-2H3,(H,17,19)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = UXQDWARBDDDTKG-UHFFFAOYSA-N
}}

'''Tromantadine''' is an [[antiviral medicine]] used to treat [[herpes simplex virus]]. It is available in a topical gel under trade names '''Viru-Merz''' and '''Viru-Merz Serol'''. Its performance is similar to [[aciclovir]].<ref>{{Cite journal|last=Ostheimer|first=K. E.|last2=Busch|first2=T.|last3=Görtelmeyer|first3=R.|last4=Hahn|first4=K. D.|date=September 1989|title=Randomized double-blind trial of tromantadine versus aciclovir in recurrent herpes orofacialis|url=https://www.ncbi.nlm.nih.gov/pubmed/2686658|journal=Arzneimittel-Forschung|volume=39|issue=9|pages=1152–1155|issn=0004-4172|pmid=2686658}}</ref><ref>{{Cite journal|last=Diezel|first=W.|last2=Michel|first2=G.|last3=Görtelmeyer|first3=R.|last4=Ostheimer|first4=K. E.|date=April 1993|title=Efficacy of tromantadine and aciclovir in the topical treatment of recurrent herpes orofacialis. Comparison in a clinical trial|url=https://www.ncbi.nlm.nih.gov/pubmed/8494582|journal=Arzneimittel-Forschung|volume=43|issue=4|pages=491–496|issn=0004-4172|pmid=8494582}}</ref>

Like [[rimantadine]], [[amantadine]], and [[adapromine]], tromantadine is a derivative of [[adamantane]].

==Mechanism==
Tromantadine inhibits the early and late events in the [[virus]] replication cycle.<ref name="pmid6297383">{{cite journal |vauthors=Rosenthal KS, Sokol MS, Ingram RL, Subramanian R, Fort RC |title=Tromantadine: inhibitor of early and late events in herpes simplex virus replication |journal=Antimicrob. Agents Chemother. |volume=22 |issue=6 |pages=1031–6 |date=December 1982 |pmid=6297383 |pmc=185716 |doi= 10.1128/aac.22.6.1031|url=http://aac.asm.org/cgi/pmidlookup?view=long&pmid=6297383}}</ref> It changes the [[glycoprotein]]s of the host cells, therefore impeding the absorption of the virus. It inhibits penetration of the virus. It also prevents [[uncoating]] of the [[virion]]s.

==References==
{{Reflist|2}}

==External links==
* [https://web.archive.org/web/20050429203941/http://www.brookespharma.com/brands_virumerz_main.htm Viru-Merz website]

{{Antibiotics and chemotherapeutics for dermatological use}}
{{Antivirals}}

[[Category:Anti-herpes virus drugs]]
[[Category:Adamantanes]]
[[Category:Acetamides]]
[[Category:Amines]]


{{antiinfective-drug-stub}}
{{dermatologic-drug-stub}}